Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TG-BIL: Bile Acid Markers in Testicular Germ Cell Tumors
NCT07463508Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Jan 2026
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Bile acid levels in healthy and tumorous testicular tissues. Started Jan 2026; status: recruiting.
Beyond the preview
Go deeper on NCT07463508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07463508.